JP2011517669A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517669A5
JP2011517669A5 JP2011501142A JP2011501142A JP2011517669A5 JP 2011517669 A5 JP2011517669 A5 JP 2011517669A5 JP 2011501142 A JP2011501142 A JP 2011501142A JP 2011501142 A JP2011501142 A JP 2011501142A JP 2011517669 A5 JP2011517669 A5 JP 2011517669A5
Authority
JP
Japan
Prior art keywords
treatment
abuse
anxiety
stress
withdrawal symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011501142A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011517669A (ja
JP5599774B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/002184 external-priority patent/WO2009118171A1/de
Publication of JP2011517669A publication Critical patent/JP2011517669A/ja
Publication of JP2011517669A5 publication Critical patent/JP2011517669A5/ja
Application granted granted Critical
Publication of JP5599774B2 publication Critical patent/JP5599774B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011501142A 2008-03-27 2009-03-25 ヒドロキシメチルシクロヘキシルアミン類 Expired - Fee Related JP5599774B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08005809.2 2008-03-27
EP08005809 2008-03-27
PCT/EP2009/002184 WO2009118171A1 (de) 2008-03-27 2009-03-25 Hydroxymethylcyclohexylamine

Publications (3)

Publication Number Publication Date
JP2011517669A JP2011517669A (ja) 2011-06-16
JP2011517669A5 true JP2011517669A5 (cg-RX-API-DMAC7.html) 2014-04-03
JP5599774B2 JP5599774B2 (ja) 2014-10-01

Family

ID=39791743

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011501142A Expired - Fee Related JP5599774B2 (ja) 2008-03-27 2009-03-25 ヒドロキシメチルシクロヘキシルアミン類

Country Status (20)

Country Link
US (1) US8288406B2 (cg-RX-API-DMAC7.html)
EP (1) EP2271613B1 (cg-RX-API-DMAC7.html)
JP (1) JP5599774B2 (cg-RX-API-DMAC7.html)
CN (1) CN102046591B (cg-RX-API-DMAC7.html)
AR (1) AR073841A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009228645B2 (cg-RX-API-DMAC7.html)
CA (1) CA2719739A1 (cg-RX-API-DMAC7.html)
CL (1) CL2009000732A1 (cg-RX-API-DMAC7.html)
CY (1) CY1115437T1 (cg-RX-API-DMAC7.html)
DK (1) DK2271613T3 (cg-RX-API-DMAC7.html)
ES (1) ES2482108T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20140650T1 (cg-RX-API-DMAC7.html)
IL (1) IL208280A (cg-RX-API-DMAC7.html)
MX (1) MX2010010448A (cg-RX-API-DMAC7.html)
PE (1) PE20091822A1 (cg-RX-API-DMAC7.html)
PL (1) PL2271613T3 (cg-RX-API-DMAC7.html)
PT (1) PT2271613E (cg-RX-API-DMAC7.html)
RU (1) RU2514192C2 (cg-RX-API-DMAC7.html)
SI (1) SI2271613T1 (cg-RX-API-DMAC7.html)
WO (1) WO2009118171A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835689B2 (en) 2008-03-27 2014-09-16 Grünenthal GmbH Substituted 4-aminocyclohexane derivatives

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2260022B1 (de) 2008-03-27 2017-01-04 Grünenthal GmbH Substituierte cyclohexyldiamine
CL2009000731A1 (es) 2008-03-27 2009-05-15 Gruenenthal Gmbh Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea.
AU2009228637B2 (en) 2008-03-27 2013-12-19 Grunenthal Gmbh (Hetero-)aryl cyclohexane derivatives
HRP20140650T1 (hr) 2008-03-27 2014-09-26 Grünenthal GmbH Hidroksimetilcikloheksilamini
JP5542119B2 (ja) 2008-03-27 2014-07-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング スピロ(5.5)ウンデカン誘導体
US8818396B2 (en) 2008-07-11 2014-08-26 Qualcomm Incorporated Apparatus and methods for associating a location fix having a quality of service with an event occuring on a wireless device
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環(4.5)癸烷衍生物
CN105924362B (zh) * 2016-02-05 2018-08-17 上海龙翔生物医药开发有限公司 芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
EP3506983B1 (en) * 2016-09-01 2021-08-25 Mebias Discovery, Inc. Substituted urea-derivatives for the treatment of pain
CN109535157B (zh) * 2018-12-03 2021-10-15 江苏科技大学 一种半蜡梅碱类似物、其合成方法及其用途
WO2021134086A1 (en) 2019-12-26 2021-07-01 Gilgamesh Pharmaceuticals, Inc. Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders
LT4084791T (lt) 2020-02-18 2025-02-25 Gilgamesh Pharmaceuticals, Inc. Specifiniai triptaminai, skirti nuotaikos sutrikimams gydyti
US12157722B1 (en) 2023-08-03 2024-12-03 Gilgamesh Pharmaceuticals, Inc. Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine
US12129234B1 (en) 2023-08-03 2024-10-29 Gilgamesh Pharmaceuticals, Inc. Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1055203A (en) * 1964-09-16 1967-01-18 Ici Ltd -ß-carboline derivatives, a process for their manufacture, and compositions containing them
US4065573A (en) * 1976-06-03 1977-12-27 The Upjohn Company 4-Amino-4-phenylcyclohexanone ketal compositions and process of use
US4115589A (en) * 1977-05-17 1978-09-19 The Upjohn Company Compounds, compositions and method of use
US4366172A (en) * 1977-09-29 1982-12-28 The Upjohn Company 4-Amino-cyclohexanols, their pharmaceutical compositions and methods of use
US4291039A (en) * 1980-08-08 1981-09-22 Miles Laboratories, Inc. Tetrahydro β-carbolines having anti-hypertensive activity
DE3309596A1 (de) * 1982-08-05 1984-04-05 Basf Ag, 6700 Ludwigshafen 2-substituierte 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-ss-carboline, ihre herstellung und verwendung als arzneimittel
US5328905A (en) * 1987-07-20 1994-07-12 Duphar International Research B.V. 8,9-anellated-1,2,3,4-tetrahydro-β-carboline derivatives
EP0620222A3 (en) * 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-beta-carbolines.
US5631265A (en) * 1994-03-11 1997-05-20 Eli Lilly And Company 8-substituted tetrahydro-beta-carbolines
US5861409A (en) * 1995-05-19 1999-01-19 Eli Lilly And Company Tetrahydro-beta-carbolines
CA2366932C (en) * 1999-04-15 2009-08-25 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
GB0012240D0 (en) * 2000-05-19 2000-07-12 Merck Sharp & Dohme Therapeutic agents
DE10123163A1 (de) 2001-05-09 2003-01-16 Gruenenthal Gmbh Substituierte Cyclohexan-1,4-diaminderivate
DE10135636A1 (de) * 2001-07-17 2003-02-06 Gruenenthal Gmbh Substituierte 4-Aminocyclohexanole
DE10213051B4 (de) * 2002-03-23 2013-03-07 Grünenthal GmbH Substituierte 4-Aminocyclohexanole
TWI329111B (en) * 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7595311B2 (en) * 2002-05-24 2009-09-29 Exelixis, Inc. Azepinoindole derivatives as pharmaceutical agents
DE10252665A1 (de) 2002-11-11 2004-06-03 Grünenthal GmbH 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10252650A1 (de) 2002-11-11 2004-05-27 Grünenthal GmbH Cyclohexyl-Harnstoff-Derivate
DE10252666A1 (de) 2002-11-11 2004-08-05 Grünenthal GmbH N-Piperidyl-cyclohexan-Derivate
ATE457299T1 (de) 2002-11-12 2010-02-15 Gruenenthal Gmbh 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ
DE50306277D1 (de) * 2002-11-12 2007-02-22 Gruenenthal Gmbh 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
EP1633751A1 (en) * 2003-06-16 2006-03-15 Chroma Therapeutics Limited Carboline and betacarboline derivatives for use as hdac enzyme inhibitors
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102004023506A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023635A1 (de) 2004-05-10 2006-04-13 Grünenthal GmbH Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023632A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Substituierte Cyclohexylcarbonsäure-Derivate
DE102004023501A1 (de) 2004-05-10 2005-12-01 Grünenthal GmbH Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023507A1 (de) 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexylessigsäure-Derivate
DE102004023508A1 (de) 2004-05-10 2005-12-08 Grünenthal GmbH Säurederivate substituierter Cyclohexyl-1,4-diamine
DE102004023522A1 (de) 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004039382A1 (de) 2004-08-13 2006-02-23 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
EP1817025A2 (en) * 2004-11-23 2007-08-15 PTC Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
EP1747779A1 (en) * 2005-07-28 2007-01-31 Laboratorios Del Dr. Esteve, S.A. Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands
WO2007062175A2 (en) * 2005-11-21 2007-05-31 Amgen Inc. Spiro-substituted tricyclic heterocycles cxcr3 antagonists
WO2007070796A1 (en) * 2005-12-15 2007-06-21 Exelixis, Inc. Azepinoindole derivatives as pharmaceutical agents
DE102005061427A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxadiazol-Derivate
DE102005061429A1 (de) 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxazol-Derivate
DE102005061428A1 (de) * 2005-12-22 2007-08-16 Grünenthal GmbH Substituierte Cyclohexylmethyl-Derivate
DE102005061430A1 (de) * 2005-12-22 2007-07-05 Grünenthal GmbH Substituierte Imidazolin-Derivate
DE102006019597A1 (de) * 2006-04-27 2007-10-31 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102006033114A1 (de) * 2006-07-18 2008-01-24 Grünenthal GmbH Spirocyclische Azaindol-Derivate
DE102006033109A1 (de) * 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
DE102006046745A1 (de) 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
DE102007009319A1 (de) * 2007-02-22 2008-08-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102007009235A1 (de) 2007-02-22 2008-09-18 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
JP5542119B2 (ja) 2008-03-27 2014-07-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング スピロ(5.5)ウンデカン誘導体
CL2009000731A1 (es) * 2008-03-27 2009-05-15 Gruenenthal Gmbh Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea.
HRP20140650T1 (hr) 2008-03-27 2014-09-26 Grünenthal GmbH Hidroksimetilcikloheksilamini
AU2009228637B2 (en) 2008-03-27 2013-12-19 Grunenthal Gmbh (Hetero-)aryl cyclohexane derivatives
KR20120075500A (ko) 2008-03-27 2012-07-06 그뤼넨탈 게엠베하 치환된 4-아미노사이클로헥산 유도체
EP2260022B1 (de) 2008-03-27 2017-01-04 Grünenthal GmbH Substituierte cyclohexyldiamine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835689B2 (en) 2008-03-27 2014-09-16 Grünenthal GmbH Substituted 4-aminocyclohexane derivatives
US9580386B2 (en) 2008-03-27 2017-02-28 Grünenthal Substituted 4-aminocyclohexane derivatives

Similar Documents

Publication Publication Date Title
AU2013369649B2 (en) Heterocyclic compounds and methods of use thereof
US7790753B2 (en) Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
TWI298635B (en) Benzimidazolone carboxylic acid derivatives
JP2011517670A5 (cg-RX-API-DMAC7.html)
ATE545413T1 (de) Antagonisten des opioidrezeptors
IL311953A (en) Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
RU2012141951A (ru) Курс лечения с использованием агониста рецептора sip
JP2009543825A5 (cg-RX-API-DMAC7.html)
JP2006515587A5 (cg-RX-API-DMAC7.html)
WO2009154780A1 (en) S1p1 receptor agonists and use thereof
RS20060315A (sr) N-(fenil(2-pirolidinil)metil)benzamid i n-(2-azepanil)fenil metil/benzamid derivati, njihovo dobijanje i terapeutska primena
PT2203444E (pt) Formas sólidas de 2-amino-3-(4-(2-amino-6-((r)-1-(4-cloro-2- (3-metil-1h-pirazol-1-il)fenil)-2,2,2-trifluoroetoxi)- pirimidin-4-il)fenil)propanoato de (s)-etilo
JP2011515430A5 (cg-RX-API-DMAC7.html)
JP2008530050A5 (cg-RX-API-DMAC7.html)
US20150266864A1 (en) Heteroaromatic compounds, method for preparing the compounds, pharmaceutical compositions, uses and method for treating acute and chronic pain
HUP0500201A2 (hu) Policiklusos vegyületek, mint potenciális alfa2-adrenoceptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
ATE475640T1 (de) Antagonisten des opioidrezeptors
JP2009500425A5 (cg-RX-API-DMAC7.html)
WO2000012482A2 (en) Indazole derivatives with 5-ht2 receptor activity
JP2004507527A5 (cg-RX-API-DMAC7.html)
TWI345467B (en) 4-imidazolines as taar's ligands
JP2011515429A5 (cg-RX-API-DMAC7.html)
CN1812987A (zh) 取代的二酮哌嗪及其作为催产素拮抗剂的用途
WO2015071831A1 (en) An improved process for minimising the formation of dehalogenated byproducts
ATE399164T1 (de) Antagonisten des opioidrezeptors